#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis III Hormone-dependent prostate cancer Atypical haemolytic uraemic syndrome Acute graft versus host disease Leukaemia Progressive familial intrahepatic cholestasis Urea cycle disorder Mantle cell lymphoma stage IV Lennox-Gastaut syndrome Arginase deficiency Transferrin decreased Thrombocytosis Hypoparathyroidism Short stature homeobox gene mutation Heritable pulmonary arterial hypertension More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Diagnostics Mast cell activation syndrome – Trials in Disease Chondrosarcoma – Life with Disease Systemic mastocytosis Malignant fibrous histiocytoma – Treatment Ewing’s sarcoma recurrent – Treatment Primary immunodeficiency syndrome – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Netherton’s syndrome Haemophilia B with anti factor IX – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [18F] CANAGLIFLOZIN Orlistat Everolimus Paclitaxel Obaluronate Aminohippuric Acid Tertomotide Daridorexant Sertraline Crofelemer BENZYDAMINE HYDROCHLORIDE Folic Acid, Anhydrous Letermovir Fludrocortisone Acetate Telisotuzumab Vedotin Brexpiprazole Fumarate Sphingomyelin (Egg) Bimekizumab Hyoscine Butylbromide Db-1303 Gskvx000000014593 More therapies…

    Learn about Your Condition

    Dementia Niemann-Pick disease Optic atrophy Herpes simplex Anxiety Lymphangioma Polycystic ovarian syndrome BRAF gene mutation Thyroid cancer Anorexia nervosa Epileptic encephalopathy Salivary gland cancer Iron overload Factor VIII deficiency Ovarian granulosa cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Hyperthermic Intrathoracic Chemotherapy with Cisplatin and Pleurectomy versus Standard Care in Patients with Malignant Pleural Effusion

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cisplatin
    Italy

  • Safety and Tolerability of AZD4956 Alone or with Saruparib in Adults with Advanced Metastatic Solid Tumors (Phase I/IIa)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Saruparib
    Spain

  • Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Mitapivat
    Greece Italy

  • A Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of LY3537031 in Adults with Irritable Bowel Syndrome‑Diarrhea (IBS‑D)

    Not yet recruiting

    2 1
    Investigated Drugs:
    • LY3537031
    Belgium Germany Spain

  • Phase 3 Study of Gildeuretinol Acetate (ALK‑001) to Assess Safety and Efficacy in Slowing Progression of Stargardt Disease in Adults

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Stargardt’s disease
    Belgium France Italy Spain

  • Study of autologous mature dendritic cell vaccine plus atezolizumab in patients with recurrent glioblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
    • Atezolizumab
    Germany
Previous Page
1 … 658 659 660 661 662 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!